Bacillary Dysentery (Shigella)
For the why behind the fact
Use this page to connect what you are memorizing.
Start with the overview when a class slide, Anki card, or qbank explanation feels too thin. Then use presentation and workup to recognize the condition, and differentials to separate look-alikes.
Overview
Plain-Language Overview
Bacillary Dysentery (Shigella) is an infection that affects the large intestine, causing inflammation and damage to the bowel lining. It is caused by bacteria called Shigella, which spread through contaminated food, water, or close contact with an infected person. The main symptoms include bloody diarrhea, abdominal pain, and fever. This condition can lead to dehydration due to frequent loose stools. It primarily affects the digestive system and can cause significant discomfort and illness, especially in young children and the elderly. Prompt diagnosis and treatment are important to manage symptoms and prevent complications.
Clinical Definition
Bacillary Dysentery (Shigella) is an acute infectious colitis caused by invasive Shigella species, primarily S. dysenteriae, S. flexneri, S. boydii, and S. sonnei. The pathogenesis involves bacterial invasion of the colonic mucosa, leading to mucosal ulceration, intense inflammatory response, and bloody, mucoid diarrhea. The infection is transmitted via the fecal-oral route and is highly contagious. Clinically, it presents with fever, abdominal cramps, tenesmus, and dysentery characterized by frequent passage of small-volume stools containing blood and mucus. The disease is significant due to its potential for causing severe dehydration, systemic toxicity, and complications such as hemolytic uremic syndrome in certain strains. Diagnosis and management are critical to reduce morbidity and prevent outbreaks.
Inciting Event
Ingestion of contaminated food or water containing Shigella bacteria
Direct fecal-oral spread, including sexual exposure, is efficient because only a very small inoculum is needed.
Outbreaks in crowded settings such as daycare centers or refugee camps
Latency Period
1 to 7 days from exposure to symptom onset, typically 1-3 days
Diagnostic Delay
Initial misattribution to viral gastroenteritis due to overlapping symptoms
Lack of stool culture or delayed stool testing for Shigella species
Mild or atypical presentations leading to under-recognition
Empiric treatment without microbiologic confirmation
Clinical Presentation
Signs & Symptoms
Small-volume bloody or mucoid stools with tenesmus define dysentery; Shigella infection can also cause watery diarrhea without visible blood.
Abdominal cramps and pain are common due to colonic inflammation.
Fever and malaise often accompany the gastrointestinal symptoms.
Tenesmus or painful straining during defecation is characteristic.
Nausea and vomiting may occur but are less prominent.
History of Present Illness
Acute onset of high fever and abdominal cramps followed by diarrhea
Progression to bloody, mucoid stools with tenesmus and urgency
Associated symptoms include nausea, vomiting, and malaise
Symptoms typically last 5-7 days but can persist longer
Past Medical History
Previous episodes of gastrointestinal infections may increase suspicion
History of immunosuppression or malnutrition can worsen disease severity
Recent travel to endemic areas or contact with infected individuals
Family History
This is an acquired infection, not an inherited disorder. Household contacts may share exposure or acquire infection from one another.
Physical Exam Findings
Abdominal tenderness localized to the lower quadrants is common in bacillary dysentery.
Signs of dehydration such as dry mucous membranes and decreased skin turgor may be present.
Fever is often observed during the acute phase of infection.
Tenesmus is a reported persistent urge or painful straining to defecate; observing it during a rectal examination is not required.
Blood and mucus in stool can sometimes be seen on digital rectal exam.
Diagnostic Workup
Diagnostic Criteria
Test stool by culture or a molecular panel. Obtain culture after a positive culture-independent result, especially for susceptibility and outbreak work. Some panels report Shigella/EIEC together. Fecal leukocytes indicate inflammation but cannot establish the cause.
Pathophysiology
Key Mechanisms
After crossing through M cells, Shigella invades colonic epithelium and spreads between cells using IcsA-mediated actin polymerization, producing mucosal inflammation and ulceration.
Shiga toxin, classically from S. dysenteriae type 1, removes an adenine from 28S rRNA in the 60S ribosomal subunit, inhibiting host protein synthesis. It is not produced by every Shigella strain.
Neutrophil recruitment causing intense inflammatory response and tissue destruction
Disruption of water and electrolyte absorption resulting in diarrhea and dehydration
| Involvement | Details |
|---|---|
| Organs | Colon is the main organ affected, where Shigella invades epithelial cells causing inflammation, ulceration, and dysentery symptoms. |
| Tissues | Colonic mucosa is the primary site of Shigella invasion and ulceration, leading to characteristic bloody diarrhea. |
| Cells | Neutrophils are recruited to the colonic mucosa and mediate tissue damage and pus formation in bacillary dysentery. |
Shigella can trigger inflammatory macrophage pyroptosis, releasing mediators such as IL-1 and facilitating tissue invasion. | |
Colonic epithelial cells are invaded and destroyed by Shigella, leading to mucosal ulceration and bloody diarrhea. | |
| Chemical Mediators | Interleukin-1 (IL-1) is released by infected macrophages, promoting inflammation and fever in bacillary dysentery. |
Tumor necrosis factor-alpha (TNF-α) amplifies the inflammatory response causing mucosal injury and systemic symptoms. | |
Prostaglandins contribute to increased intestinal secretion and motility, worsening diarrhea. |
Treatments
Pharmacological Treatments
Ciprofloxacin
- Mechanism:
Inhibits bacterial DNA gyrase and topoisomerase IV, preventing DNA replication in Shigella.
- Side effects:
Tendon rupture
Gastrointestinal upset
Photosensitivity
- Clinical role:
Oral option when antibiotics are indicated and the isolate is susceptible; resistance is common. Severe illness, immune impairment or transmission concerns may justify treatment; mild illness often needs hydration alone.
Azithromycin
- Mechanism:
Binds to the 50S ribosomal subunit, inhibiting bacterial protein synthesis in Shigella.
- Side effects:
Gastrointestinal upset
QT prolongation
Hepatotoxicity
- Clinical role:
Oral option selected using susceptibility and local resistance. Ceftriaxone is another option for appropriate cases; suspected extensively resistant disease requires specialist input rather than an automatic standard regimen.
Trimethoprim-sulfamethoxazole
- Mechanism:
Inhibits sequential steps in bacterial folate synthesis, impairing DNA synthesis in Shigella.
- Side effects:
Rash
Bone marrow suppression
Hyperkalemia
- Clinical role:
Use only when susceptibility is documented; widespread resistance makes routine empiric use unreliable.
Non-pharmacological Treatments
Oral rehydration is central; severe dehydration or inability to drink may require IV fluids. Many mild infections recover without antibiotics.
Implement strict hand hygiene and sanitation measures to reduce transmission of Shigella.
Avoid antimotility drugs, such as loperamide, in shigellosis because they can worsen illness.
Prevention
Pharmacological Prevention
No widely available vaccine currently exists for Shigella; antibiotic prophylaxis is not routinely recommended.
Do not routinely give preventive antibiotics to asymptomatic contacts. Evaluate symptomatic contacts and follow public-health instructions during outbreaks.
Non-pharmacological Prevention
Hand hygiene with soap and water is critical to prevent fecal-oral transmission.
Safe drinking water and proper sanitation reduce infection risk.
Food safety measures including thorough cooking and avoiding contaminated food.
Stay out of childcare/school while diarrheal and follow local return-to-work rules for food handlers and healthcare workers; avoid food preparation for others while ill.
Address sexual transmission: CDC dedicated prevention guidance advises avoiding sex until at least 2 weeks after diarrhea ends, with hygiene/barriers afterward because shedding can persist.
Outcome & Complications
Complications
Toxin-producing strains, especially S. dysenteriae type 1, can cause HUS: microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury.
Severe dehydration from profuse diarrhea can lead to hypovolemic shock.
Sepsis may develop in immunocompromised or severely ill patients.
Rectal prolapse can occur in young children with severe dysentery.
Reactive arthritis may develop as a post-infectious complication.
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Bacillary Dysentery (Shigella) versus Enterohemorrhagic Escherichia coli (EHEC) infection
Bacillary Dysentery (Shigella) | Enterohemorrhagic Escherichia coli (EHEC) infection |
|---|---|
Infection with Shigella species invading colonic mucosa | Shiga-toxin-producing E. coli, including O157:H7 and non-O157 strains; epithelial attachment and toxin injury rather than Shigella-type invasion. |
Bloody diarrhea with high fever and abdominal cramps | Often causes bloody diarrhea without high fever |
Positive stool culture for Shigella species | Test for Shiga toxin/toxin genes and culture for O157 as appropriate. Avoid antibiotics and antimotility agents when STEC is suspected or confirmed because of HUS risk. |
Bacillary Dysentery (Shigella) versus Campylobacter jejuni infection
Bacillary Dysentery (Shigella) | Campylobacter jejuni infection |
|---|---|
Infection with Shigella, a non-motile gram-negative rod | Infection with Campylobacter jejuni, a curved gram-negative rod |
Often associated with fecal-oral transmission from contaminated water or food | Often associated with undercooked poultry or unpasteurized milk |
Bloody diarrhea with prominent tenesmus and high fever | Diarrhea may be watery or bloody, often preceded by fever and malaise |
Bacillary Dysentery (Shigella) versus Clostridioides difficile colitis
Bacillary Dysentery (Shigella) | Clostridioides difficile colitis |
|---|---|
Fecal-oral infection can occur with or without prior antibiotics. | Recent antibiotics or healthcare exposure increase risk, but community-associated infection can occur without either. |
Bloody diarrhea with mucus and severe abdominal cramps | Profuse watery diarrhea, often without blood |
Positive stool culture or PCR for Shigella species | Compatible diarrhea with an appropriate toxin/NAAT testing algorithm. A molecular positive alone can reflect colonization; toxin assays have imperfect sensitivity. |
Bacillary Dysentery (Shigella) versus Amebic dysentery (Entamoeba histolytica infection)
Bacillary Dysentery (Shigella) | Amebic dysentery (Entamoeba histolytica infection) |
|---|---|
Infection with gram-negative bacterial Shigella species | Infection with protozoan parasite Entamoeba histolytica |
Acute onset with mucosal ulceration and bloody diarrhea | May be acute or more indolent; colonic flask-shaped ulcers and possible liver abscess are characteristic, but neither is required. |
Positive stool culture or PCR for Shigella species | Use E. histolytica-specific stool PCR or antigen testing; microscopy alone cannot reliably separate pathogenic E. histolytica from E. dispar. |
Bacillary Dysentery (Shigella) versus Salmonella enterocolitis
Bacillary Dysentery (Shigella) | Salmonella enterocolitis |
|---|---|
Infection with non-motile Shigella species | Infection with motile Salmonella species |
Fecal-oral transmission from contaminated water or food | Often linked to contaminated poultry, eggs, or reptiles |
Often fever and tenesmus with dysentery, but severity varies. | Watery or bloody diarrhea with variable fever; fever intensity alone does not distinguish Salmonella from Shigella. |